Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
This study found a decrease in biologics drug use during pregnancy and highlights the necessity for personalized therapeutic approaches. Geographic variations in biologic drug use emphasize the need for educational initiatives about the risk-benefit profiles of these therapies during pregnancy.
Authors
- Ester Sapigni
- Valeria Belleudi (ORCID: https://orcid.org/0000-0002-8286-443X)
- Luca L’Abbate (ORCID: https://orcid.org/0000-0003-0232-6402)
- Marco Massari (ORCID: https://orcid.org/0000-0002-0745-7519)
- Aurora Puccini
- Martina Zanforlini
- Ersilia Lucenteforte (ORCID: https://orcid.org/0000-0001-5608-5902)
- Sabrina Giometto (ORCID: https://orcid.org/0000-0002-3409-1778)
- Paolo Carta
- Antonio Addis (ORCID: https://orcid.org/0000-0003-0962-9959)
- Stefania Spila Alegiani (ORCID: https://orcid.org/0000-0003-0656-1346)
- Sara Lopes (ORCID: https://orcid.org/0000-0002-4322-8529)
- Michela Servadio (ORCID: https://orcid.org/0000-0003-2165-2895)
- Stefano Ledda
- Gianluca Trifirò (ORCID: https://orcid.org/0000-0003-1147-7296)
- Olivia Leoni (ORCID: https://orcid.org/0000-0002-6906-2424)
- Paolo Stella
- Giovambattista De Sarro (ORCID: https://orcid.org/0000-0002-7629-6579)
- Andrea Spini (ORCID: https://orcid.org/0000-0001-7496-5575)
- Ylenia Ingrasciotta (ORCID: https://orcid.org/0000-0002-9549-6111)
- Lucian Ejlli
- Paola Rossi (ORCID: https://orcid.org/0009-0002-7749-9711)
- Antea Maria Pia Mangano
- Rita Francesca Scarpelli
- Francesco Balducci
Institutions
- University of Pisa (IT)
- University of Messina (IT)
- University of Verona (IT)
- Magna Graecia University (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- Medica (Italy) (IT)
- Regione Autonoma della Sardegna
- University of Florence (IT)
Publication Details
- Journal
- Expert Opinion on Biological Therapy
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1080/14712598.2024.2442452
- Citations
- 1
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Agenzia Italiana del Farmaco, Ministero della Salute